LongBio Pharma (Suzhou) Co., Ltd. (1779)
Market Closed
30 Sep, 08:00 AM
HKEX HKEX Primary 105. 80
HKD +5.1
+5.0645%
6.45B Market Cap
- P/E Ratio
- Div Yield
146,500 Volume
- Eps
100.7 HKD
Previous Close Want to track 1779 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
LongBio Pharma (Suzhou) Co., Ltd. (1779) Statistics
Valuation metrics
Market Cap 6.45B
Enterprise value 6.44B
Trailing P/E (ttm) -
Forward P/E -
PEG ratio -
Price/Sales (ttm) 2,558.7
Price/Book (mrq) 4.75
Enterprise Value/Revenue 2,177.64
Enterprise Value/EBITDA -25.52
Overview
Shares outstanding 75.06M
Float 33.76M
Shares short -
% Held by insiders 0.48%
% Held by institutions 0.39%
Average volume (10 days) 52.7K
Average volume (90 days) 198.64K
Price summary
52-Week low 72.65
52-Week high 165.9
Beta -
50-Day moving average 110.94
200-Day moving average 112.82
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -
Operating margin -39.34%
Operational effectiveness
Return on assets -0.77%
Return on equity -1.25%
Income Statement
Revenue (ttm) 2.96M
Revenue per share (ttm) 0.04
Quarterly revenue growth (yoy) 2.87%
Gross profit (ttm) 2.96M
EBITDA -252.33M
Net income to common (ttm) -253.49M
Diluted EPS (ttm) -3.66
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 1.43B
Total cash per share (mrq) 16.49
Total debt (mrq) 66.05M
Total Debt/Equity (mrq) 5
Current ratio (mrq) 8.95%
Book value per share (mrq) 17.82
Cash Flow
Cash flow statement -196.01M
Levered free cash flow (LFCF) -175.58M
2026 © Marketlog. All Rights Reserved.
